Chat with Client Services
Site Search
For 100 years, forward-thinking medical laboratory professionals have pioneered new concepts in diagnostic medicine. Now it’s your turn.
ARUP President and Chief Medical Officer Tracy George, MD, has a message for women building STEM careers: Believe in yourself.
Cases of Lyme disease, Rocky Mountain spotted fever, and other tickborne illnesses are rising across the U.S. ARUP Consult’s testing resources can aid clinicians in diagnosing tickborne diseases.
ARUP Launches New Bioinformatics Platform for Better, Faster Next Generation Sequencing Test Results
ARUP’s next generation sequencing (NGS) tests are now faster and more precise thanks to the launch of Rio, a new world-class bioinformatics pipeline and analytics platform.
ARUP Consult has released updated resources on Endocrine Testing in Transgender Adults and diagnosis of Male Hypogonadism. Also new are two comparison tools for ARUP’s testosterone and estrogen tests.
High-volume laboratory testing just got better and faster at ARUP with the addition of a state-of-the-art Roche chemistry and immunoassay platform that is at the center of ARUP’s Automated Core Lab.
Join us for a look at ARUP’s accomplishments in scientific innovation and meet our committed scientists, laboratory professionals, and healthcare advisory consultants who make ARUP an industry leader.
ARUP President and Chief Medical Officer Tracy George, MD, wants to establish a multidisciplinary, multinational network of centers focused on mast cell diagnosis, therapy, and education.
Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles.
Videos and podcasts produced by ARUP Laboratories about the function of COVID-19 vaccines and the challenges in navigating the pandemic have earned top prizes from the 26th annual Viddy Awards.
ARUP Consult® has released new and updated resources on Prenatal Testing for Chromosomal Abnormalities and Neural Tube Defects, Soft Tissue Sarcomas, and COVID.
Two years into the COVID-19 pandemic, when the highly contagious Omicron variant of SARS-CoV-2 has infected millions in the United States alone, most of us have some immunity against the virus.
